화이자 주식회사
CL ˙ SNSE ˙ US7170811035
SecurityCL:PFE / Pfizer Inc.
InstitutionNixon Peabody Trust Co
Latest Disclosed Ownership8,713 shares
Latest Disclosed Value $ 244,653
Nixon Peabody Trust Co reports 7.11% increase in ownership of PFE / Pfizer Inc.

On April 27, 2026 - Nixon Peabody Trust Co filed a 13F-HR form disclosing ownership of 8,713 shares of Pfizer Inc. (CL:PFE) valued at $244,653 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 8,135 shares of Pfizer Inc.. This represents a change in shares of 7.11% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F Pfizer Com 717081103 8,713 578 7.11 245 20.79 0.0194
2026-02-06 2025-12-31 13F Pfizer Com 717081103 8,135 8,135 203 0.0153
2023-03-15 2022-09-30 13F/A-1 Pfizer Com 717081103 0 -3,989 -100.00 0 -100.00
2022-11-10 2022-09-30 13F Pfizer Com 717081103 0 -3,989 0
2022-08-11 2022-06-30 13F Pfizer Com 717081103 3,989 -2,280 -36.37 209 -35.69 0.0945
2022-05-13 2022-03-31 13F Pfizer Com 717081103 6,269 -1,129 -15.26 325 -25.63 0.1119
2022-02-08 2021-12-31 13F Pfizer Com 717081103 7,398 7,398 437 0.1323
2019-04-19 2019-03-31 13F PFIZER INC COM Common Stock 717081103 0 -4,901 -100.00 0 -100.00
2019-01-23 2018-12-31 13F PFIZER INC COM Common Stock 717081103 4,901 330 7.22 214 5.94 0.1686
2018-10-25 2018-09-30 13F PFIZER INC COM Common Stock 717081103 4,571 4,571 202 0.1380
2016-10-24 2016-09-30 13F PFIZER INC COM Common Stock 717081103 0 -21,195 -100.00 0 -100.00
2016-07-08 2016-06-30 13F PFIZER INC COM Common Stock 717081103 21,195 -100 -0.47 746 18.23 0.6477
2016-04-20 2016-03-31 13F PFIZER INC COM Common Stock 717081103 21,295 -522 -2.39 631 -10.37 0.5612
2016-01-13 2015-12-31 13F PFIZER INC COM Common Stock 717081103 21,817 21,817 704 0.6417
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.